Dig a little deeper into what we've discussed in the past.
Opioids & Addiction: A Public-Health Approach to Change
Thomas H. Carr, Executive Director, Center for Drug Policy and Enforcement, University of Baltimore
Jennifer L. Martin, Deputy Commissioner, Population Health and Disease Prevention, Baltimore City Health Department
View Ms. Martin's PowerPoint presentation.
More About the Dialogue
Trend data on overdose deaths and judicial proceedings show the tragedy of the opioid crisis, its blight on rural and urban America and the failure to resolve it. Where initiatives have made a positive difference, they include a bundle of evidence-based public health, criminal justice and policy actions. The panel of experts addressed the core of a public-health approach to changing the trends in addiction, incarceration and death from opioids.
About the Panelists
Thomas H. Carr is the Executive Director of the Office of National Drug Control Policy’s (ONDCP) Washington/Baltimore High Intensity Drug Trafficking Area (HIDTA) Program, a position he has held since 1994. He also serves as Executive Director of the University of Baltimore’s Center for Drug Policy and Enforcement.
Mr. Carr has designed and implemented more than 150 drug task forces, 18 drug treatment/criminal justice task forces and five drug prevention task forces during the last 23 years. He currently administers 42 drug task forces and a regional intelligence center that supports more than 150 federal, state and local law enforcement agencies in Maryland, Washington, D.C, Virginia, and West Virginia.
In response to the nation’s opioid epidemic, Mr. Carr is working with nine other HIDTAs and the Office of National Drug Control Policy on the Opioid Response Strategy (ORS). This strategy resulted in the creation of a public health-public safety partnership supported by the Centers for Disease Control and Prevention, and the hiring of 24 drug intelligence officers and 24 public health analysts. The ORS has led to the interdisciplinary sharing of opioid data between law enforcement and public health agencies.
Mr. Carr spearheaded the development of the ODMAP, a real-time overdose syndromic surveillance system used to identify spikes in fatal and non-fatal overdoses. In July 2017, Mr. Carr and the ODMAP development team received the Special Achievement in GIS award from Esri Corporation.
Prior to accepting his position with the Washington/Baltimore HIDTA, Mr. Carr was a Lt. Colonel with the Maryland State Police and retired as chief of the Bureau of Drug Enforcement. He graduated from Towson University and was first in his class at the Maryland State Police Academy, class of 1971. He attended the FBI National Academy, the DEA Drug Commanders School and the Federal Executive Institute. He served as an adjunct instructor with the University of Maryland from 1993 to 1999.
Jennifer L. Martin, J.D., M.A.
Jennifer L. Martin, J.D., M.A., is the Deputy Commissioner: Population Health and Disease Prevention at the Baltimore City Health Department. As Deputy Commissioner, she oversees the agency’s two public health clinics; its HIV/AIDS prevention and treatment programs, including the Ryan White program and syringe exchange programs; the overdose response program; the acute and communicable disease monitoring and investigation program; the Non-Emergency Medical Transportation program, the public health preparedness program, and performance management and quality improvement for the agency.
She also represents the Health Commissioner at the Maryland Association of County Health Officers and oversee the agency’s Local Health Improvement Council.
Prior to becoming Deputy Commissioner, Ms. Martin served as both the Director and Deputy Director of the Office of Public Health Preparedness and Response overseeing the agency’s bio-surveillance and bioterrorism activities, COOP planning, health and medical response planning, and animal protection services planning. She served on a number of planning groups including the Maryland Region III Health and Medical Task Force and the Maryland State PHEP group.
Ms. Martin serves on the Governor’s Emergency Management Advisory Council in Maryland and is a 2007 graduate of the University of Maryland School of Law and a 2013 graduate of the Naval Postgraduate School.
What is the Rosenberg Dialogue Series?
The Henry A. Rosenberg Dialogue Series is made possible by the generous support of the Henry and Ruth Blaustein Rosenberg Foundation and the University of Baltimore Foundation. It aims to explore opportunities for the private sector to work in partnership with the public and nonprofit (nongovernmental organizations) sectors to create a vibrant and economically strong society.
Developing Performance Management Systems for Public-Private Partnerships
Public-private arrangements are increasingly used to address large and complicated endeavors. Managing the performance of these initiatives, however, requires special technical and managerial tools. This dialogue brought together an Italian expert on such performance management systems with experts at the federal and state levels in the U.S. Our U.S. experts used real estate as the focus for their comments.
Carmine Bianchi, Ph.D., Professor of Business and Public Management, University of Palermo
Steve Cassard, Director of Special Projects, Maryland Economic Development Corporation
Robert Helwig, J.D., Installations, Housing and Utilities Privatization, Office of the Secretary of Defense (2000-14)
The Opioid Addiction Epidemic: Causes, Consequences and Treatments
Pain management and the promotion of prescription medicines led many patients to addiction and the nation to a crisis in managing it. Public- and private-sector experts held an interactive and in-depth discussion of the opioid crisis, sharing insights into lessons learned and next steps followed by an audience Q&A.
Lorena de Leon, MBA, director, National Clinical Programs, OPTUMCare
Kimberly A. Johnson, Ph.D., director, Center for Substance Abuse Treatment, SAMHSA
Yngvild Olsen, M.D., M.P.H., FASAM, medical director, Institutes for Behavior Resources Inc/REACH Health Services, ASAM
Cybersecurity: Is Patient Privacy Extinct?
Lessons Learned for Secure, Reliable Public-Private Systems
Privacy breaches to electronic health records and related financial data are happening faster and more frequently than ever. Recently, a breach at a major provider gave unauthorized access to the personal health information of 78.8 million. In light of this and other disturbing developments in the realm of health care privacy, academic and public- and private sector experts led an interactive and in-depth discussion about patient privacy, discussing the issue as it relates to the interaction between public-sector laws and private-sector initiatives and offering insight into lessons learned and next steps.
Kirk Grothe, CEO, Livanta
Charles Tumosa, professor of the practice in the School of Criminal Justice at the University of Baltimore
Public-Private Partnerships in an Age of Austerity: State-Local and Federal-State Dynamics
The Rosenberg Dialogue Series explores opportunities for the private sector to work in partnership with the public and nonprofit (nongovernmental organization) sectors to create a vibrant and economically strong society. This dialogue delves into how federalism and intergovernmental relations influence the type and extent of such partnerships.
John Callahan, executive in residence and program director, UB College of Public Affairs, School of Health and Human Services
John Willis, executive in residence, UB College of Public Affairs, School of Public and International Affairs
Maryland Hospitals and Environmental Sustainability: Green Health-Care Facilities
Health care is a vital component of Maryland's economy, but health-care facilities face many worksite and environmental challenges. Economic, social and environmental health impacts of energy consumption; water usage; material purchase, use and wastage; as well as the quantity and toxicity of the chemicals used in and for health care must be managed concurrently.
For health-care providers, there is also a moral imperative—an ethical obligation—to create a resilient health-care system that benefits citizens as well as organized stakeholders. Achieving this balance within resource constraints requires management efficiency, operational effectiveness, cost containment while maintaining quality of care, and ensuring employees' health, general safety and environmental sustainability.
How can these goals be achieved affordably and reliably? What are the opportunities for public-private-sector collaboration?
Joan Plisko, technical director, Maryland Hospitals for a Healthy Environment
Clifford Mitchell, director, Environmental Health Bureau, Prevention and Health Promotion Administration, Maryland Department of Health and Mental Hygiene
Access to Pharmaceutical Products and Services for Underserved Populations: Public- and Private-Sector Roles in the United States and India
The front line of our public health system is not a doctor's office, an emergency room or even a clinic, but our local pharmacies. The community pharmacist is the first and often most frequent point of contact that many people have with the organized health-care system. Medicine shortages are the most visible consequence of a changed and interconnected world, but underserved populations confront unmet needs for access to pharmacist services and clinical information.
Education for community pharmacists' clinical roles continues to require significant curricular change and mentored experiential education. This has led to an undersupply of pharmacists globally, with implications for unmet medical needs and avoidable drug interactions that manifest in other areas of the health-care system: crisis visits to emergency rooms; hospitalizations; and secondary, perhaps chronic, disabilities.
Magaly Rodriguez de Bittner, professor and chair, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy
Anne Y.F. Lin, dean, School of Pharmacy, Notre Dame of Maryland University
Prasada Reddy, pharmacist, Taastrup Apotek, Copenhagen area, Denmark; Tamil Nadu Dr. M.G.R. Medical University; RMES's College of Pharmacy